Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond

Author:

Bianchi Alberto12,von Deimling Markus13,Pallauf Maximilian14,Yanagisawa Takafumi15,Kawada Tatsushi16,Mostafaei Hadi17,Quhal Fahad18ORCID,Laukhtina Ekaterina19ORCID,Rajwa Pawel110,Majdoub Muhammad111,Motlagh Reza Sari112,Pradere Benjamin113ORCID,Karakiewicz Pierre I.14,Cerruto Maria Angela2,Antonelli Alessandro2,Shariat Shahrokh F.19151617ORCID

Affiliation:

1. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

2. Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy

3. Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

4. Department of Urology, Paracelsus Medical University Salzburg, University Hospital Salzburg, Salzburg, Austria

5. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan

6. Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

7. Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

8. Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia

9. Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia

10. Department of Urology, Medical University of Silesia, Zabrze, Poland

11. Department of Urology, Hillel Yaffe Medical Center, Hadera, Israel

12. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

13. Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France

14. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Québec, Canada

15. Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan

16. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

17. Department of Urology, Weill Cornell Medical College, New York, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3